Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionFDx Advisors, Inc.
Latest Disclosed Ownership4,156 shares
Latest Disclosed Value $ 635
FDx Advisors, Inc. ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 1, 2026 - FDx Advisors, Inc. filed a 13F-HR form disclosing ownership of 4,156 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $634,829 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 2, 2024 disclosing 0 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $616,750 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,156 4,156 1 0.2027
2024-08-02 2024-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 0 -4,694 -100.00 0 0.0000
2024-05-03 2024-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,694 -11,675 -71.32 0 -100.00 0.0689
2024-02-13 2023-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 16,369 651 4.14 2 0.00 0.1278
2023-11-02 2023-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 15,718 -13,946 -47.01 2 -50.00 0.1329
2023-07-17 2023-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 29,664 -28,123 -48.67 3 -60.00 0.1642
2023-05-22 2023-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 57,787 0 0.00 5 0.00 0.2280
2023-02-10 2022-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 57,787 -936 -1.59 5 -99.89 0.2280
2022-11-10 2022-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 58,723 -5,878 -9.10 4,464 -18.26 0.2002
2022-08-03 2022-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 64,601 1,784 2.84 5,461 -0.93 0.2050
2022-05-03 2022-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 62,817 3,847 6.52 5,512 6.86 0.1868
2022-02-01 2021-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 58,970 11,566 24.40 5,158 33.04 0.1427
2021-10-08 2021-09-30 13F ADR NOVARTIS AG SPONSORED ADR 66987V109 47,404 3,481 7.93 3,877 -3.27 0.1235
2021-08-05 2021-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 43,923 1,529 3.61 4,008 10.60 0.1331
2021-04-14 2021-03-31 13F/A-1 NOVARTIS AG SPONSORED ADR ADR 66987V109 42,394 -4,831 -10.23 3,624 -18.73 0.1367
2021-04-13 2021-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 3,624 -43,601 42,394 180,769.8012
2021-02-08 2020-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 47,225 4,609 10.82 4,459 20.32 0.1838
2020-11-12 2020-09-30 13F NOVAVAX INC COM ADR 66987V109 42,616 718 1.71 3,706 1.28 0.1735
2020-07-22 2020-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 41,898 2,895 7.42 3,659 13.77 0.1917
2020-05-22 2020-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR ADR 66987V109 39,003 5,139 15.18 3,216 0.28 0.2091
2020-05-13 2020-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 32,191 -1,673 53 3,133.0376
2020-02-12 2019-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 33,864 5,151 17.94 3,207 28.54 0.1771
2019-11-07 2019-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 28,713 -21,544 -42.87 2,495 -45.63 0.1727
2019-07-19 2019-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 50,257 9,190 22.38 4,589 16.24 0.1798
2019-05-14 2019-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 41,067 15,604 61.28 3,948 80.69 0.1601
2019-04-29 2018-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR ADR 66987V109 25,463 -20,820 -44.98 2,185 -45.21 0.1796
2019-02-07 2018-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 55,609 9,326 4,772 107,576.3799
2018-11-13 2018-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 46,283 878 1.93 3,988 16.27 0.1481
2018-08-08 2018-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 45,405 -2,600 -5.42 3,430 -11.62 0.1239
2018-05-02 2018-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 48,005 2,698 5.95 3,881 2.02 0.1158
2018-02-09 2017-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 45,307 7,035 18.38 3,804 15.76 0.1034
2017-11-03 2017-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 38,272 5,536 16.91 3,286 20.23 0.0902
2017-08-11 2017-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 32,736 -32,833 -50.07 2,733 -43.88 0.0809
2017-05-15 2017-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 65,569 1,593 2.49 4,870 4.51 0.1489
2017-02-14 2016-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 63,976 31,790 98.77 4,660 83.39 0.1340
2016-11-14 2016-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 32,186 381 1.20 2,541 -3.16 0.1057
2016-08-15 2016-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 31,805 -4,784 -13.07 2,624 -1.02 0.1186
2016-05-17 2016-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 36,589 4,093 12.60 2,651 -5.19 0.1210
2016-02-17 2015-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 32,496 3,571 12.35 2,796 5.19 0.1269
2015-11-16 2015-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 28,925 -3,085 -9.64 2,659 -15.22 0.2284
2015-08-14 2015-06-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 32,010 2,510 8.51 3,135 7.62 0.1556
2015-05-18 2015-03-31 13F/A-1 NOVARTIS AG-SPONSORED ADR ADR 66987V109 29,500 -13,693 -31.70 2,913 -27.21 0.0643
2015-05-15 2015-03-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 29,126 295
2015-02-17 2014-12-31 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 43,193 -1,473 -3.30 4,002 -4.80 0.2437
2014-11-17 2014-09-30 13F NOVARTIS AG-SPONSORED ADR ADR 66987V109 44,666 -14,095 -23.99 4,204 -20.98 0.2727
2014-08-15 2014-06-30 13F NOVARTIS AG-ADR ADR 66987V109 58,761 12,710 27.60 5,320 35.89 0.3484
2014-05-15 2014-03-31 13F NOVARTIS AG-ADR ADR 66987V109 46,051 -6,169 -11.81 3,915 -6.65 0.3267
2014-02-14 2013-12-31 13F NOVARTIS AG-ADR ADR 66987V109 52,220 -12,186 -18.92 4,194 -15.12 0.4179
2013-11-13 2013-09-30 13F NOVARTIS AG-ADR Common 66987V109 64,406 -819 -1.26 4,941 7.13 0.5832
2013-08-13 2013-06-30 13F NVS Common 66987V109 65,225 65,225 4,612 0.6081
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.